News | January 06, 2026
PHARMEXCIL holds high-level talks with government to boost India’s pharma exports
India’s pharmaceutical sector stands at a pivotal inflection point
India’s pharmaceutical sector stands at a pivotal inflection point
For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
The new site will produce next-generation synthetic medicine active pharmaceutical ingredients
VitiPure serves as essential solubilizers, emulsifiers, and bioavailability enhancers in drug formulations
Ipca Laboratories receives three observations from USFDA for API facility at Tarapur
PLI scheme for Bulk Drugs has a total budgetary outlay of Rs. 6,940 crore
A key highlight will be Brenntag’s qualified amino acids portfolio
Both companies will jointly execute development and scale-up of multiple strategic APIs, including late-stage NCE-1 opportunities
Subscribe To Our Newsletter & Stay Updated
